Before You Buy Zomedica Stock, Stop and Consider These 3 Things
In case you haven't been paying attention, pets are responsible for a growing portion of the economy right now. Pandemic-fueled isolation has accelerated a long-running trend of increasing pet adoption, and soaring demand for veterinary services.
Anyone that's taken their fur baby to the vet for a serious condition knows diagnostic services can be expensive, and slow. That's why everyone's been talking about Zomedica (NYSEMKT: ZOM) and its recently launched diagnostic tool for adrenal gland and thyroid gland conditions.
Image source: Getty Images.
Source Fool.com
